COGT
Cogent Biosciences, Inc. Healthcare - Biotechnology Investor Relations →
Cogent Biosciences, Inc. (COGT) closed at $37.08 as of 2026-02-02, trading 217.2% above its 200-week moving average of $11.69. The stock moved further from the line this week, up from 211.0% last week. With a 14-week RSI of 72, COGT is in overbought territory.
Over the past 362 weeks of data, COGT has crossed below its 200-week moving average 3 times. On average, these episodes lasted 84 weeks. Historically, investors who bought COGT at the start of these episodes saw an average one-year return of +74.8%.
With a market cap of $5.7 billion, COGT is a mid-cap stock. Free cash flow yield is currently negative, meaning the company is burning cash. Return on equity stands at -95.4%. The stock trades at 26.7x book value.
Share count has increased 152.2% over three years, indicating dilution.
Over the past 7 years, a hypothetical investment of $100 in COGT would have grown to $211, compared to $272 for the S&P 500. COGT has returned 11.3% annualized vs 15.4% for the index, underperforming the broader market over this period.
In the past 12 months, corporate insiders have made 1 open-market purchase totaling $24,999,993.
Free cash flow has been declining. A deteriorating cash flow trend warrants extra scrutiny — the stock may be cheap for a reason.
Growth of $100: COGT vs S&P 500
Monthly data normalized to $100 at start. Vertical dashed lines mark 200-week MA touches.
What Happens After COGT Crosses Below the Line?
Across 3 historical episodes, buying COGT when it crossed below its 200-week moving average produced an average return of +89.3% after 12 months (median +38.0%), compared to +15.3% for the S&P 500 over the same periods. 67% of those episodes were profitable after one year. After 24 months, the average return was +22.0% vs +56.5% for the index.
Each line shows $100 invested at the moment COGT crossed below its 200-week MA. Bold blue = stock average. Gray dashed = S&P 500 average over same periods.
Historical Touches
COGT has crossed below its 200-week MA 3 times with an average 1-year return of +74.8% after recovery.
| Crossed Below | Recovered | Weeks | Max Depth | 1-Year Return | Return Since Touch |
|---|---|---|---|---|---|
| Mar 2019 | Jul 2022 | 174 | 94.4% | -87.2% | +124.5% |
| Oct 2023 | Aug 2024 | 44 | 53.1% | +34.8% | +319.9% |
| Nov 2024 | Jul 2025 | 34 | 54.6% | +276.9% | +316.6% |
| Average | 84 | — | +74.8% | — |
Not financial advice. This is an educational tool. Past performance does not guarantee future results. Do your own research before making investment decisions.
Data as of Friday close, 2026-02-02